CVE-2014-125041: A vulnerability classified as critical was found in Miccighel PR-CWT
CVE-2014-125041 is a medium-severity flaw (CVSS 5.5) affecting progetto-complementi. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
A vulnerability classified as critical was found in Miccighel PR-CWT. This vulnerability affects unknown code. The manipulation leads to sql injection. The patch is identified as e412127d07004668e5a213932c94807d87067a1f. It is recommended to apply a patch to fix this issue. VDB-217486 is the identifier assigned to this vulnerability.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 5.5 (Medium) |
| Attack vector | Adjacent network |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.7% (top 47%) |
| CISA exploited list | No |
| Weakness | CWE-89 |
| Published | 2023-01-05 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2014-125041?
progetto-complementi: upgrade to 2014-06-25. Exact commands for each OS are on this page.
Is CVE-2014-125041 being exploited?
CVE-2014-125041 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2014-125041 affect?
CVE-2014-125041 affects progetto-complementi. Severity is medium (CVSS 5.5). A vulnerability classified as critical was found in Miccighel PR-CWT. This vulnerability affects unknown code. The manipulation leads to sql injection. The patch is identified as e412127d07004668e5a213932c94807d87067a1f. It is recommended t
How urgent is CVE-2014-125041?
Priority 32/100. No elevated risk signals yet.